Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in lebanon

Abstract

Even though the clinical role of pharmacy practice in Middle Eastern countries is limited, this study highlighted the impact of the pharmacist on cost through the implementation of restriction policy during dispensing procedure, leading to a cost reduction by four folds.

Oral Ppi VS IV Ppi in Hospitalized Patient

“…There is significant statistical difference between IVPPIs and oral PPIs cost, the IVPPIs calculated cost was 20$ per ampule, which includes the cost of the IV vial, 100 mg solution bag, 5ml syringe IV line, angiocath, and local anesthetic cream in comparison to oral PPI price which was 3 $ per capsule [30]. This also confirmed in the questioner results of this study (Appendix II).…”

“…RQ4: which route is more time consuming (nurses interview) the IV route is more time consuming for both nurse and patient than the oral route which needs less time as mentioned in previous studies and seen in the results of the questioner ( Appendix II) [32] RQ5: Is it possible to reduce the costs if we applied oral route when possible instead of parenteral route? (Interview with the responsible pharmacists confirmed that, knowing the big price difference between the IV and oral route) [30].…”

“…Which PPI formula or route is more costly? The doctors and Pharmacists answered this question (Appendix II) based on legal ministry of health pricing structures for both formula, The cost of IVPPIs was 20$ which includes the cost of the IV vial, 100 mg solution bag, 5ml syringe, IV line, angiocath and local anesthetic cream in comparison to oral PPI price which was 3 $ per capsule [30].…”

Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature

“…Interventions were in following areas antimicrobial management [17][18][19][20][21][22], targeted drug programmes [23][24][25][26], multidimensional clinical pharmacy service [27][28][29], paediatric programmes [30,31], renal specialist [32,33], pharmacotherapeutic optimisation [34,35], intensive care service [36,37] and neurosurgery [38]. All intervention types have been identified in previous reviews of the literature [10][11][12][13].…”

“…Pharmacists discontinued unnecessary vitamin D supplements over a 1 year period, resulting in cost savings of US$111,282.40 [24]. A group of hospital pharmacists reviewed the appropriateness of prescribing iv esomeprazole resulting in savings of US$21,233 per month [25]. Pharmacists in Taiwan reviewing the appropriateness of activated protein C therapy in septic patients over a 2 year period, demonstrated a reduction in total direct medical costs [26].…”